Skip to main content
. Author manuscript; available in PMC: 2020 May 10.
Published in final edited form as: Clin Trials. 2020 Feb 3;17(2):184–194. doi: 10.1177/1740774520901514

Table 3.

Comparison of clinical trial attitudes and reasons for participation or declination of clinical trial offers as perceived by physicians and staff and reported by cancer patients.

Physician/staff
N = 120
Patient
N = 150
P value
Clinical trial attitudes
Positive attitudes N (%) N (%)
 Being part of a clinical trial helps patients be more in control of their disease and treatment 65 (57.0) 104 (69.3) 0.04
 A clinical trial absolutely provides the best treatment available 24 (20.7) 90 (60.0) <0.001
 The benefits to patients of being in a clinical trial outweigh any risks or harms 50 (43.9) 85 (57.0) 0.03
 Clinical trials are important to the advancement of medical science and clinical cancer care 115 (99.1) 148 (98.7) 0.72
Negative attitudes
 Clinical trials are only offered to people whose disease is hopeless 10 (8.7) 41 (27.3) <0.001
 Being in a clinical trial does not help patients personally 2 (1.8) 49 (32.9) <0.001
 Patients who enroll in a clinical trial are gambling with their life 13 (11.3) 31 (20.8) 0.04
 Doctors only offer clinical trials as a last resort 14 (12.2) 35 (23.5) 0.019
 Patients enroll in clinical trials as a last resort 29 (25.4) 36 (24.0) 0.79
 Clinical trials are only good for the doctors, not for the patients 5 (4.3) 20 (13.4) 0.013
Reasons to participate in a clinical trial N = 21
 To get better treatment 108 (93.9) 20 (95.2) 1.00
 Help people in the future 92 (80.0) 18 (85.7) 0.76
 To get newest treatment available 107 (92.2) 19 (90.5) 0.68
 Doctor recommended it 100 (84.0) 19 (90.5) 0.74
 Family wanted it 56 (50.0) 7 (33.3) 0.07
 Wanted a better chance at a cure 94 (80.3) 20 (95.2) 0.12
 Had no better options 101 (85.6) 8 (38.1) <0.001
Reasons to decline participation in a clinical trial N = 11
Patient-related factors
  Language/cultural barriers 69 (57.5) 3 (27.3) 0.052
  Religious reasons 27 (22.5) 0 (0.0) 0.021
  Lack of understanding about research trials 76 (63.3) 1 (9.1) 0.001
  Lack of interest in clinical trials 41 (34.2) 4 (40.0) 0.71
Psychosocial factors
  Mistrust of the medical system/science/Researchers 83 (69.2) 4 (36.4) 0.043
  Feeling physically or emotionally Overwhelmed 77 (64.2) 2 (18.2) 0.003
Logistic factors
  Inconvenience 71 (59.2) 3 (27.3) 0.04
  Lack of transportation 54 (45.0) 4 (36.4) 0.75
  Family/personal responsibilities 43 (35.8) 2 (18.2) 0.33
Trial-related factors
  Invasive procedures 50 (41.7) 1 (9.1) 0.02
  Concerns about toxicity 72 (60.0) 2 (18.2) 0.006
  Concerns about randomization or getting a placebo 85 (70.8) 3 (27.3) 0.005
  Preference for a proven treatment 69 (57.5) 5 (45.5) 0.53
Financial concerns
  Lack of insurance coverage 35 (29.2) 1 (9.1) 0.29
  Additional out-of-pocket costs 44 (36.7) 2 (18.2) 0.33